Krensavage Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History
Krensavage Asset Management, LLC
- $178 Million
- Q3 2024
A detailed history of Krensavage Asset Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 1,498,074 shares of ENTA stock, worth $13.6 Million. This represents 8.7% of its overall portfolio holdings.
Number of Shares
1,498,074
Previous 1,251,338
19.72%
Holding current value
$13.6 Million
Previous $16.2 Million
4.37%
% of portfolio
8.7%
Previous 7.45%
Shares
30 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$19.1 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$16.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.1MShares$10 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1MShares$9.08 Million0.17% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $188M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...